[1] Michalopoulos GK, Bhushan B. Liver regeneration: biological and pathological mechanisms and implications. Nature reviews Gastroenterology & hepatology. 2021;18(1):40-55. https://doi.org/10.1038/s41575-020-0342-4.
[2] Devarbhavi H, Asrani SK, Arab JP, Nartey YA, Pose E, Kamath PS. Global burden of liver disease: 2023 update. Journal of hepatology. 2023;79(2):516-37. https://doi.org/10.1016/j.jhep.2023.03.017.
[3] Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, S taging, and M anagement of H epatocellular C arcinoma: 2018 P ractice G uidance by the A merican A ssociation for the S tudy of L iver D iseases. Hepatology. 2018;68(2):723-50.
[4] Yuze Y, Mingda W, Lanqing Y, Xinfei X, Ping Z, Feng S, et al. Progress in the update of 2024 European Association for the Study of the Liver clinical practice guidelines for management of hepatocellular carcinoma. Chinese Journal of Digestive Surgery. 2025;24(2):198-205. https://dx.doi.org/10.3760/cma.j.cn115610-20241224-00580.
[5] Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660.
[6] Patel V, Kothari S, Dayal A, Patel N, Akruwala S. Evaluation of histopathological spectrum of hepatic lesions in liver biopsies in a tertiary care hospital. Panacea journal of medical sciences Учредители: IP Innovative Publication. 2022;12(3):690-5.
[7] International Agency for Research on Cancer, editor. WHO classification of tumours of the digestive system. International agency for research on cancer; 2019.
[8] Shetty JK, Prasad HL, Hidangmayum A. The Spectrum of Histopathological Lesions Presenting as a Hepatic Nodule and Their Relationship With Serum Alpha-Fetoprotein Level. Journal of Health and Allied Sciences NU. 2026. https://doi.org/10.25259/JHASNU_242_2025.
[9] Ilyas SI, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma—evolving concepts and therapeutic strategies. Nature reviews Clinical oncology. 2018;15(2):95-111. https://doi.org/10.1038/nrclinonc.2017.157.
[10] Costa AC, Santa-Cruz F, Guimarães H, Paz AR, Costa EA, Figueiredo JL, Ferraz ÁA. Primary hepatic neuroendocrine tumor: A case report and literature review. International Journal of Surgery Case Reports. 2020;72:1-4. https://doi.org/10.1016/j.ijscr.2020.05.057.
[11] Noor M, Leyva A, Patacsil SJ, Patel M, Smith C. Hepatic angiosarcoma: a case presentation. Cureus. 2020;12(2). https://doi.org/10.7759/cureus.6848.
[12] Park JH, Kim JH. Pathologic differential diagnosis of metastatic carcinoma in the liver. Clinical and molecular hepatology. 2018;25(1):12-20. https://doi.org/10.3350/cmh.2018.0067.
[13] Choi JH. Histological and molecular evaluation of liver biopsies: A practical and updated review. International Journal of Molecular Sciences. 2025;26(16):7729. https://doi.org/10.3390/ijms26167729.
[14] Gopal P, Hu X, Robert ME, Zhang X. The evolving role of liver biopsy: Current applications and future prospects. Hepatology Communications. 2025;9(1):e0628. https://doi.org/10.1097/HC9.0000000000000628.
[15] Cao M, Zeng J, Wang J, Jiang J. A comprehensive analysis of percutaneous liver biopsy characteristics and pathological manifestations in a large patient cohort (2009–2024). BMC gastroenterology. 2025;25(1):67. https://doi.org/10.1186/s12876-025-03646-z.
[16] Alwahaibi N, Alwahaibi M. Liver biopsy in the modern era: from traditional techniques to artificial intelligence and multi-omics integration. Frontiers in Medicine. 2025;12:1678753.
https://doi.org/10.3389/fmed.2025.1678753.